Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

2003 Vaccine Research Seminars

Future Seminars | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

Seminars are held on the NIH campus in Building 40, Conference Rooms 1201 & 1203, on Tuesdays at 4:00 PM (except as noted).





Dec. 9, 2003 Robert Doms University of Pennsylvania Emerging and already emerged: West Nile virus and HIV infection of cells
Dec. 2, 2003 Susan Zolla-Pazner New York University Re-examining the V3 Loop and its Role in Inducing Protective Antibodies
Nov. 25, 2003 Stefan Kaufmann Max Planck Institute Natural Immune Response to Tuberculosis: Lessons for Rational Vaccine Design
Nov. 18, 2003 Jon Yewdell NIAID, NIH In Vivo Veritas: Routes of Viral Antigen Presentation to CD8+ T Cells
Nov. 4, 2003 Philippa Marrack National Jewish Med. Res. Ctr T Cell Ligands and the Cells Presenting Them
Oct. 28, 2003 Steve Rosenberg NCI, NIH The Development of T-cell Based Immunotherapies for the Treatment of Patients with Cancer
Oct. 21, 2003 Robert Siliciano Johns Hopkins University Viral Reservoirs and the Logic of Antiretroviral Therapy for HIV Infection
Oct. 7, 2003 Richard Wyatt Vaccine Research Center, NIH Structural and Immunogenic Analysis of HIV Envelope Glycoproteins
June 10, 2003 Dr. Joern Schmitz Harvard University The roles of cellular and humoral immunity in controlling SIV replication in vivo
June 3, 2003 Lewis Lanier University of California, San Francisco NK cell immunity against viral infection
May 27, 2003 Klaus Uberla Ruhr University Lentiviral vectors based on simian immunodeficiency viruses for gene transfer and vaccination
May 20, 2003 Joern Schmitz Harvard University The roles of cellular and humoral immunity in controlling SIV replication in vivo
May 13, 2003 John Shiver Merck Comparison of viral vector approaches for HIV-1 vaccine development
May 6, 2003 Julie McElrath Fred Hutchinson Cancer Center Induction of T cell immunity by HIV-1 immunization and infection
Apr. 29, 2003 Mike McCune Gladstone Institute HIV-induced disruption of the CD8+ T cell compartment
Apr. 22, 2003 Wes Sundquist University of Utah Cellular Factors and HIV Budding
Apr. 15, 2003 Raymond Welsh University of Massachusetts T cell cross-reactivity and heterologous immunity
Apr. 9, 2003 Tom Wickham GenVec, Inc. Modifying the receptor specificity of adenovirus vectors to improve their efficiency and specificity for vaccine and other applications
Mar. 25, 2003 Robin Weiss University College London Blood group antigens and retrovirus transmission
Mar. 11, 2003 Genoveffa Franchini National Cancer Institute, NIH Skewing of dominant responses in macaques immunized with multigenic vaccines
Mar. 4, 2003 Leo Lefrancois University of Connecticut Health Center Migration and function of non-lymphoid effector and memory T cells
Feb. 25, 2003 Jean Stephenne GlaxoSmithKline Biologics Later Stages of Vaccine Development at GlaxoSmithKline Biologics
Feb. 4, 2003 Michael Lederman Case Western Reserve Qualitative and quantitative immune deficits in HIV infection. Does where you were determine where you are?
Jan. 28, 2003 Warner Greene Gladstone Institute New insights into the pathogenic interplay of HIV with its cellular host
Jan. 21, 2003 Mario Stevenson University of Massachusetts Functions of primate lentiviral Nef proteins
Jan. 14, 2003 Robert Seder Vaccine Research Center, NIH Mechanisms controlling Th1 memory cell differentiation: implications for vaccine development against intracellular infections requiring cellular immune responses

View Past Seminars

back to top

Last Updated January 25, 2012